patent

Latest stories

  • in Health care

    Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma, Sandoz

    by

    Thousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the District of New Jersey in a patent infringement lawsuit against Sandoz Inc. and Zydus Pharmaceuticals (USA), Inc. The decision affirms the permanent injunction entered by the district court prohibiting Sandoz and […] More

  • Samsung Faces $303 Million Jury Verdict for Patent Infringement

    by

    Computer-memory company Netlist convinced a federal jury in Texas on Friday to award it more than $303 million (roughly Rs. 2,500 crore) for Samsung Electronics‘s infringement of several patents related to improvements in data processing. The jury in Marshall, Texas determined after a six-day trial that Samsung’s “memory modules” for high-performance computing willfully infringed all […] More

  • Google Wins Appeal in $20 Million Patent Lawsuit Over Chrome’s Anti-Malware Technology

    by

    Alphabet’s Google on Tuesday convinced a US appeals court to cancel three anti-malware patents at the heart of a Texas jury’s $20 million (roughly Rs. 163 crore) infringement verdict against the company. The US Court of Appeals for the Federal Circuit said that Alfonso Cioffi and Allen Rozman’s patents were invalid because they contained inventions that were not […] More

  • Oppo Rollable Phone Spotted on Patent Site; Invisible Camera Design Hinted: Report

    Oppo Rollable Phone Spotted on Patent Site; Invisible Camera Design Hinted: Report

    by

    Oppo may introduce a new rollable smartphone to the market in the near future. A patent application from the company has reportedly been spotted on the China National Intellectual Property Administration (CNIPA) website. The company has also launched the Oppo Find N2 Flip and the Oppo Find N2 foldable smartphones in December 2022. Oppo is […] More

  • in Health care

    Teva, Viatris win US appeal in patent fight over Parkinson’s drug

    Teva, Viatris win US appeal in patent fight over Parkinson's drug

    by

    New Delhi: Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Parkinson’s disease drug Neupro, clearing an obstacle for Teva’s Actavis Laboratories UT Inc and Viatris‘ Mylan Technologies Inc to sell generic versions of the drug. The U.S. Court of Appeals for the Federal Circuit agreed […] More

  • in Health care

    Moderna fends off Arbutus appeal in COVID vaccine patent fight

    Moderna fends off Arbutus appeal in COVID vaccine patent fight

    by

    US:  U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent related to the companies’ legal fight over Moderna’s blockbuster COVID-19 vaccines. The U.S. Court of Appeals for the Federal Circuit upheld a U.S. Patent and Trademark Office tribunal’s ruling that the patent for Arbutus’ lipid […] More

  • in Health care

    Pfizer, BioNTech dragged to Court over COVID vaccine patent infringement once again

    by

    US: Arbutus Biopharma on Tuesday sued U.S. drugmaker Pfizer Inc. and its German partner BioNTech SE in a New Jersey district court, claiming their mRNA COVID-19 vaccines infringe five of Arbutus’ patents. Arbutus, along with its licensee Genevant Sciences, is seeking damages, including reasonable royalties, over the use of lipid nanoparticle (LNP) delivery technology in Pfizer/BioNTech vaccines […] More